Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

72,086 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Preoperative cholesterol level as a new independent predictive factor of survival in patients with metastatic renal cell carcinoma treated with cyto-reductive nephrectomy.
Lee H, Kim YJ, Hwang EC, Kang SH, Hong SH, Chung J, Kwon TG, Kwak C, Kim HH, Oh JJ, Lee SC, Hong SK, Lee SE, Byun SS; KOrean Renal Cell Carcinoma (KORCC) Group. Lee H, et al. Among authors: lee sc, lee se. BMC Cancer. 2017 May 25;17(1):364. doi: 10.1186/s12885-017-3322-5. BMC Cancer. 2017. PMID: 28545466 Free PMC article.
Application of the International Metastatic Renal Cell Carcinoma Database Consortium and Memorial Sloan Kettering Cancer Center Risk Models in Patients with Metastatic Non-Clear Cell Renal Cell Carcinoma: A Multi-Institutional Retrospective Study Using the Korean Metastatic Renal Cell Carcinoma Registry.
Kim JK, Kim SH, Song MK, Joo J, Seo SI, Kwak C, Jeong CW, Song C, Hwang EC, Seo IY, Lee H, Hong SH, Park JY, Chung J. Kim JK, et al. Among authors: lee h. Cancer Res Treat. 2019 Apr;51(2):758-768. doi: 10.4143/crt.2018.421. Epub 2018 Sep 7. Cancer Res Treat. 2019. PMID: 30189720 Free PMC article.
Survival and clinical prognostic factors in metastatic non-clear cell renal cell carcinoma treated with targeted therapy: A multi-institutional, retrospective study using the Korean metastatic renal cell carcinoma registry.
Kim JK, Kim SH, Song MK, Joo J, Seo SI, Kwak C, Jeong CW, Song C, Hwang EC, Seo IY, Lee H, Hong SH, Park JY, Chung J. Kim JK, et al. Among authors: lee h. Cancer Med. 2019 Jul;8(7):3401-3410. doi: 10.1002/cam4.2222. Epub 2019 May 9. Cancer Med. 2019. PMID: 31070307 Free PMC article.
The platelet-to-lymphocyte ratio as a significant prognostic factor to predict survival outcomes in patients with synchronous metastatic renal cell carcinoma.
Yuk HD, Kang M, Hwang EC, Park JY, Jeong CW, Song C, Seo SI, Byun SS, Kwak C, Hong SH, Chung J, Lee H; Korean Renal Cancer Study (KRoCS) Group. Yuk HD, et al. Among authors: lee h. Investig Clin Urol. 2020 Sep;61(5):475-481. doi: 10.4111/icu.20200002. Epub 2020 Jul 23. Investig Clin Urol. 2020. PMID: 32734724 Free PMC article.
72,086 results
You have reached the last available page of results. Please see the User Guide for more information.